The Efficacy and Safety of CT-P13 vs Infliximab in RA The Efficacy and Safety of CT-P13 vs Infliximab in RA

CT-P13, a biosimilar of reference infliximab, may be a safe and effective treatment option for patients with active rheumatoid arthritis.Arthritis Research & Therapy
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news